Literature DB >> 17764507

Weak blood group B phenotypes may be caused by variations in the CCAAT-binding factor/NF-Y enhancer region of the ABO gene.

Axel Seltsam1, Franz F Wagner, Daniela Grüger, Christa D Gupta, Christina Bade-Doeding, Rainer Blasczyk.   

Abstract

BACKGROUND: Binding of CCAAT-binding factor NF-Y (CBF/NF-Y) to a 43-bp repeat unit in the minisatellite region in the 5' region of the ABO gene (CBF/NF-Y enhancer region) plays an important role in regulating the transcription of ABO genes. The common ABO alleles were found to have CBF/NF-Y enhancer regions with specific numbers of 43-bp minisatellite repeats.
MATERIAL AND METHODS: Blood samples from four healthy blood donors with weak B phenotypes were subjected to extensive ABO genotyping, including nucleotide sequencing of the 5' regulatory region containing the CBF/NF-Y enhancer.
RESULTS: The coding region of the ABO genes exhibited common ABO*B101-heterozygous genotypes in all samples, but unexpected variations were observed in the CBF/NF-Y enhancer region. In two cases, the CBF/NF-Y enhancer motifs did not exhibit the expected ABO allele dependency. One, an AB(weak) sample was heterozygous for ABO*A101 and ABO*B101 but homozygous for the ABO*B101-specific CBF/NF-Y motif. The second had a common ABO*B101/ABO*O01 genotype but was heterozygous for ABO*A101- and ABO*O01-specific enhancer motifs. In the other two samples, novel CBF/NF-Y motifs were found. One contained a shortened version of an otherwise ABO*B101-specific CBF/NF-Y motif, and the other had a single-base substitution located 12 bp upstream from the beginning of the first 43-bp repeat of an ABO*B101-specific CBF/NF-Y enhancer sequence.
CONCLUSION: The frequency of variations in the CBF/NF-Y region of the ABO gene in these samples with presumably common ABO*B101 alleles suggests that weak blood group B phenotypes may be caused by sequence variations in the CBF/NF-Y regulatory region.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17764507     DOI: 10.1111/j.1537-2995.2007.01475.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  4 in total

1.  A B101-O16 hybrid sequence is responsible for a Bweak phenotype in the ABO blood group.

Authors:  Hao Pang; Chunmei Li; Pei Li; Mei Ding; Baojie Wang
Journal:  Int J Legal Med       Date:  2014-07-27       Impact factor: 2.686

2.  Application of Blood Group Genotyping by Next-Generation Sequencing in Various Immunohaematology Cases.

Authors:  Tae Yeul Kim; HongBi Yu; Minh-Trang Thi Phan; Ja-Hyun Jang; Duck Cho
Journal:  Transfus Med Hemother       Date:  2021-08-11       Impact factor: 4.040

3.  Genome-wide association identifies the ABO blood group as a major locus associated with serum levels of soluble E-selectin.

Authors:  Andrew D Paterson; Maria F Lopes-Virella; Daryl Waggott; Andrew P Boright; S Mohsen Hosseini; Rickey E Carter; Enqing Shen; Lucia Mirea; Bhupinder Bharaj; Lei Sun; Shelley B Bull
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-09-03       Impact factor: 8.311

4.  Six splice site variations, three of them novel, in the ABO gene occurring in nine individuals with ABO subtypes.

Authors:  Xiaozhen Hong; Yanling Ying; Jingjing Zhang; Shu Chen; Xianguo Xu; Ji He; Faming Zhu
Journal:  J Transl Med       Date:  2021-11-22       Impact factor: 5.531

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.